State Street Corp T2 Biosystems, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.36 - $0.57 $23,778 - $37,649	66,052 Added 11.38%	646,500 $339,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.69 $485,521 - $788,973	466,848 Added 410.96%	580,448 $691,000
Q4 2020 Feb 16, 2021	BUY	$1.06 - $1.51 $97,414 - $138,769	91,900 Added 423.5%	113,600 $141,000
Q1 2020 May 11, 2020	BUY	$0.28 - $1.23 $6,076 - $26,691	21,700 New	21,700 $14,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.